ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 35797463

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.

Döhner H and 22 others. Blood, 2022. Cited by 2,892 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Papers, record 35797463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35797463

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
PubMed
Journal
Blood
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2,892
iCite
Relative citation ratio, by iCite
235
iCite
Revised in PubMed
2023-02-09
PubMed

Authors23

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Döhner HHartmuthttps://orcid.org/0000-0003-2116-5536
2Wei AHAndrew Hhttps://orcid.org/0000-0002-7514-3298
3Appelbaum FRFrederick R
4Craddock CCharles
5DiNardo CDCourtney Dhttps://orcid.org/0000-0001-9003-0390
6Dombret HHervé
7Ebert BLBenjamin Lhttps://orcid.org/0000-0003-0197-5451
8Fenaux PPierre
9Godley LALucy A
10Hasserjian RPRobert Phttps://orcid.org/0000-0002-7753-0697

1 to 10 of 23Source PubMed

See all 23 authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Leukemia, Myeloid, AcuteMajor topic
Adult
Humans
Mutation
Neoplasm, Residual
Nucleophosmin
Prognosis
Proto-Oncogene Proteins c-bcl-2

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT06199557A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS PatientsBackgroundClinicalTrials.gov
NCT06845592
Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia
BackgroundClinicalTrials.gov
NCT07060001Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease MarkerBackgroundClinicalTrials.gov
NCT07154823A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic MalignanciesBackgroundClinicalTrials.gov
NCT07283094FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid LeukemiaBackgroundClinicalTrials.gov

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in36,136,361How thinly can one slice the AML diagnostic pie?https://conductscience.org/library/papers/36136361

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by2,159

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,892 citations.

PMIDTitleJournalYearIn PapersSource
42,985,053Integrated single-cell and bulk transcriptomic profiling reveals coagulation-associated heterogeneity and prognostic SPINT2 in acute myeloid leukemia.Front Cell Dev Biol2026https://conductscience.org/library/papers/42985053PubMed
42,982,943Clinical characteristics and outcomes of extramedullary acute myeloid leukemia: a 20-year referral center experience.Int J Hematol2026https://conductscience.org/library/papers/42982943PubMed
42,981,093Overall Survival in Adults With Acute Myeloid Leukemia Initiating Quizartinib vs Midostaurin With Chemotherapy.JAMA Netw Open2026https://conductscience.org/library/papers/42981093PubMed
42,979,513Improved multistate survival in younger AML patients over time.Hemasphere2026https://conductscience.org/library/papers/42979513PubMed
42,975,681SPINK2 knockdown reduces proliferation and promotes cell death in MLL-MLLT3-rearranged THP-1 cells.Histochem Cell Biol2026https://conductscience.org/library/papers/42975681PubMed
42,974,127Personalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics.Drug Des Devel Ther2026https://conductscience.org/library/papers/42974127PubMed
42,974,114Mechanisms and Therapeutic Potential of Resveratrol: Focus on its Effect on Leukemia.Onco Targets Ther2026https://conductscience.org/library/papers/42974114PubMed
42,964,454Therapy-related T-lymphoblastic lymphoma following acute myeloid leukemia remission with IDH2 mutation persistence.Leuk Res Rep2026https://conductscience.org/library/papers/42964454PubMed
42,964,349vardictcpp: a C++ reimplementation of VarDict variant caller.GigaByte2026https://conductscience.org/library/papers/42964349PubMed
42,964,156A nutrition-inflammation index weighted toward disease burden: the lactate dehydrogenase-to-albumin ratio in TP53-mutated myeloid neoplasms.Front Nutr2026https://conductscience.org/library/papers/42964156PubMed

1 to 10 of 2,159

See all 2,159 cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
FLT32,322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
IDH13,417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
IDH23,418PubTator's text mininghttps://conductscience.org/library/genes/3418NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35797463

GET https://conductscience.org/api/papers/v1/35797463/authors?page=2

API referenceFor AI assistants